In DLBCL, SLC27A2 expression levels are highest in individuals aged over 60 years (G2) (Fig. 5B), while in AML, SLC27A2 expression levels are lowest in individuals aged over 60 years (G2) (Fig. 5C). This evidence concerns the gene SLC27A2 and acute myeloid leukemia.